We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




EEG-Based AI Technology Accurately Diagnoses Alzheimer’s and Dementia

By HospiMedica International staff writers
Posted on 23 Dec 2025

Dementia, including Alzheimer’s disease, is difficult to diagnose early, even though timely detection is critical for slowing disease progression and preserving quality of life. More...

Symptoms often overlap with normal aging, and current diagnostic pathways can be slow, expensive, and resource-intensive. Researchers have now shown that analyzing the brain’s electrical activity can reliably separate healthy individuals from those with different forms of dementia. The findings demonstrate that artificial intelligence (AI) applied to EEG data can deliver accurate, rapid, and interpretable dementia detection.

The work was led by Örebro University (Örebro, Sweden), where researchers developed two complementary AI models for EEG-based dementia classification. The first approach combines temporal convolutional networks with long short-term memory networks to capture both short- and long-term patterns in brain signals. The system analyzes standard EEG recordings and evaluates changes across multiple frequency bands, including alpha, beta, and gamma waves.

A second model focuses on efficiency and privacy. Using a compact neural network design and federated learning, the system allows multiple healthcare providers to collaboratively train AI models without sharing sensitive patient data. Despite being under one megabyte in size, the model maintains high diagnostic performance while ensuring patient privacy and enabling deployment on portable or low-resource devices.

In the first study, the AI distinguished among healthy individuals, Alzheimer’s disease, and frontotemporal dementia with over 80 percent accuracy. An explainable AI layer highlighted which EEG signal segments most influenced the diagnosis, helping clinicians understand how decisions were made. In the second study, the privacy-focused model achieved more than 97 percent accuracy while keeping patient data decentralized. Together, the studies, published in Frontiers, demonstrate that EEG-based AI can be both highly accurate and clinically interpretable.

The findings suggest EEG combined with AI could become a rapid, low-cost, and privacy-safe screening tool for early dementia detection. Because EEG is already widely available and inexpensive, these models could extend dementia assessment beyond specialist clinics to primary care and even future home-based testing. The researchers plan to expand their work to larger and more diverse datasets and include additional dementia types such as vascular dementia and Lewy body dementia.

“Early diagnosis is crucial in order to be able to take proactive measures that slow down the progression of the disease and improve the patient's quality of life,” said Muhammad Hanif, researcher in informatics at Örebro University. “If solutions like this are fully implemented, it could ease the burden for everyone involved – patients, care staff, relatives and healthcare professionals.”

Related Links:
Örebro University


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.